vimarsana.com

Page 14 - மருத்துவ ப்ராபர்டீஸ் நம்பிக்கை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3 Great Income Stocks to Buy Right Now - Channel3000 com

Channel3000.com January 1, 2021 6:15 AM newsfeedback@fool.com (Ryan Downie) Posted: Updated: January 3, 2021 6:37 AM Dividend stocks are an important tool for income investing. Surveying the market for stocks with high dividend yields, stable business models, and growth opportunities can improve income flows over the long term. This is important for retirees or anyone who prefers to have income returns that can be redeployed into other opportunities. The following three stocks embody the above characteristics and are great options for income investors. 1. Gilead Sciences Gilead Sciences (NASDAQ: GILD) is a pharmaceutical stock that is on pace to exceed $20 billion in drug sales this year. Gilead holds a strong presence in the HIV treatment space, with a portfolio that includes Biktarvy, Descovy, Genvoya, Odefsey, and Truvada. The company also develops drugs for viral diseases, inflammatory conditions, and oncology. Veklury has been another major seller for Gilead i

3 Great Income Stocks to Buy Right Now

Jan 1, 2021 at 7:15AM Dividend stocks are an important tool for income investing. Surveying the market for stocks with high dividend yields, stable business models, and growth opportunities can improve income flows over the long term. This is important for retirees or anyone who prefers to have income returns that can be redeployed into other opportunities. The following three stocks embody the above characteristics and are great options for income investors. 1. Gilead Sciences Gilead Sciences (NASDAQ:GILD) is a pharmaceutical stock that is on pace to exceed $20 billion in drug sales this year. Gilead holds a strong presence in the HIV treatment space, with a portfolio that includes Biktarvy, Descovy, Genvoya, Odefsey, and Truvada. The company also develops drugs for viral diseases, inflammatory conditions, and oncology. Veklury has been another major seller for Gilead in 2020 due to its use in treating COVID-19.

3 Dividend Stocks to Bankroll Your Retirement

5 at 5: Your Daily Digest for Real Estate Investing, 12/14/2020

5 at 5: Your Daily Digest for Real Estate Investing, 12/14/2020 Millionacres 12/14/2020 Marc Rapport © Provided by The Motley Fool 5 at 5: Your Daily Digest for Real Estate Investing, 12/14/2020 Blackstone bets billions more on life sciences CRE, unsold hotel rooms near a billion, multifamily loans reflect pandemic stress, Redford s Sundance exit plan, and three reliable REITs for income. In Today s News The Wall Street Journal reports today that The Blackstone Group (NYSE: BX) is amping up its bet on biotechnology lab space and other life-sciences real estate, agreeing to pay $3.45 billion for a portfolio of buildings primarily in the active Cambridge, Massachusetts, market. Why it matters: With a $341 billion portfolio, Blackstone is one of the world s largest real estate investors. Its Americas real estate chief says life science is one of the firm s high-conviction bets property types Blackstone believes are among the biggest beneficiaries of

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.